Chinese Clinical Oncology ›› 2018, Vol. 23 ›› Issue (5): 472-475.

Previous Articles     Next Articles

A review of value assessment frameworks of antitumor drugs in foreign countries

  

  1. A review of value assessment frameworks of antitumor drugs in foreign countries
  • Received:2017-12-27 Revised:2018-03-07 Online:2018-05-31 Published:2018-06-07

PDF (PC)

877

Abstract: The soaring cost of new antitumor drugs has prompted calls for more attention to the value of these products. In response to rapidly increasing health care spending， several organizations such as ASCO, ESMO, ICER, NCCN and DrugAbacus have developed frameworks to systematically assess the value of new drugs. Value assessment frameworks vary in their definition of components of value and their approach to assessment. This review analyzes and discusses several assessment frameworks in foreign countries by reviewing and synthesizing relevant literature， in order to help us build a framework for the evaluation of the value of antitumor drugs applicable to our country and carry out value-based treatment decisions.

Key words: Antitumor drugs, Value frameworks, Review

CLC Number: 

  • R730
[1] XU Jing, LI Jie, ZHANG Meijing, CHEN Longpei, LONG fei, WANG Wei, ZHAN Xianbao.. Adherence to NCCN antiemesis guideline for chemotherapy induced nausea and vomiting： A retrospective study in changhai hospital [J]. Chinese Clinical Oncology, 2018, 23(5): 440-443.
[2] MEI Wenjuan, LI Xin, WU Xiaoyan, ZHANG Zhoulong. . The value of acoustic radiation force impulse imaging in differentiating benign and malignant thyroid nodules [J]. Chinese Clinical Oncology, 2018, 23(5): 444-448.
[3] MAO Haiyan, LIU Siping, ZHANG Lei, TONG Jiandong, BO Ping. . The biological effects of neuropilin-1 in the development of gastrointestinal cancers [J]. Chinese Clinical Oncology, 2018, 23(5): 467-471.
[4] . Ｐｒｏｇｒｅｓｓｉｏｎ ｏｆ ｍｏｎｏｃｏｌｏｎａｌ ａｎｔｉｂｏｄｉｅｓ ｆｏｒ ｃｏｌｏｒｅｃｔａｌ ｃａｎｃｅｒ ｉｎ 2008 [J]. Chinese Clinical Oncology, 2009, 14(1): 1-.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] . [J]. Chinese Clinical Oncology, 2009, 14(1): 96 .
[2] . [J]. Chinese Clinical Oncology, 2009, 14(1): 89 .
[3] . [J]. Chinese Clinical Oncology, 2009, 14(1): 80 .
[4] . [J]. Chinese Clinical Oncology, 2009, 14(1): 74 .
[5] . [J]. Chinese Clinical Oncology, 2009, 14(1): 47 .
[6] ＸＵＷｅｉ-ｇｕｏ，ＹＡＮＧＸｉａｏ-ｑｉｎｇ，ＨＡＯＳｈｉ-ｚｈｕ，ＳＯＮＧＪｉ-ｎｉｎｇ，ＺＨＡＮＧＰｅｎｇ-ｄｏｎｇ，ＨＵＣｈａｎ-ｃｈａｎ，ＷＡＮＧＷｅｎ-ｙａ. Ｔｈｅｅｘｐｒｅｓｓｉｏｎｏｆｎｅｕｒｏｐｉｌｉｎ-１ａｎｄｉｔｓｃｏｒｒｅｌａｔｉｏｎｗｉｔｈａｎｇｉｏｇｅｎｅｓｉｓｉｎｃｏｌｏｒｅｃｔａｌｃａｎｃｅ[J]. Chinese Clinical Oncology, 2009, 14(1): 29 .
[7] . [J]. Chinese Clinical Oncology, 2009, 14(1): 70 .
[8] . [J]. Chinese Clinical Oncology, 2009, 14(1): 43 .
[9] . [J]. Chinese Clinical Oncology, 2009, 14(1): 51 .
[10] . ＥｘｐｒｅｓｓｉｏｎｏｆＥｚｒｉｎａｎｄＡＫＴ２ａｎｄｉｔｓｃｌｉｎｉｃａｌｓｉｇｎｉｆｉｃａｎｃｅｉｎｈｕｍａｎｃｏｌｏｒｅｃｔａｌｃａｒｃｉｎｏｍａ[J]. Chinese Clinical Oncology, 2009, 14(1): 25 .
Copyright © Chinese Clinical Oncology, All Rights Reserved.
Tel: 025-84400143 85862116　E-mail: lczlx@csco.org.cn; lczlx@vip.163.com
Powered by Beijing Magtech Co. Ltd